Laura Braunohler
Adult Health · Grand Rapids, MINPI 1598914228
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,111 of the $8,062 with a category attached, or 63.4%. Abbott accounts for 75.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $3,317 and has fallen 60.5% since, to $1,310 in 2025. Among adult health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $71.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Pfizer$589
- Boehringer Ingelheim$288
- Alnylam Pharmaceuticals Inc.$251
- Novartis$208
- Boston Scientific$199
- plus $415 from 11 others
What the payments were for
- Travel & lodging$2,90036%
- Food & beverage$5,11163%
- Education$521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 48 | $6,113 |
| Pfizer | 22 | $589 |
| Boehringer Ingelheim | 5 | $288 |
| Alnylam Pharmaceuticals Inc. | 7 | $251 |
| Novartis | 11 | $208 |
| Boston Scientific | 3 | $199 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $118 |
| Sanofi | 1 | $86 |
| Scpharmaceuticals Inc. | 4 | $64 |
| Merck | 2 | $29 |
| Cvrx, Inc. | 1 | $27 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Impulse Dynamics (USA) Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| AstraZeneca | 1 | $14 |
| Elutia, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$2,573
- CARDIOMEMS$2,530
- VYNDAQEL$230
- MitraClip$168
- CardioMEMS HF System$160
- JARDIANCE$125
- AMVUTTRA$118
- WATCHMAN Access System$114
How this compares
$8,062 in reported general payments places this provider in the 95th percentile of 527 adult health providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 26 | $608,563 |
| EntrestoSacubitril/Valsartan | 342 | $431,042 |
| VyndaqelTafamidis Meglumine | 17 | $384,180 |
| JardianceEmpagliflozin | 278 | $259,659 |
| EliquisApixaban | 202 | $244,643 |
| FarxigaDapagliflozin Propanediol | 153 | $156,299 |
| XareltoRivaroxaban | 50 | $62,995 |
| Torsemide | 396 | $12,717 |
| Metoprolol Succinate | 359 | $8,988 |
| Potassium Chloride | 166 | $7,223 |
| Spironolactone | 465 | $5,067 |
| Eplerenone | 45 | $4,431 |
| Carvedilol | 178 | $2,764 |
| Bumetanide | 28 | $2,760 |
| Atorvastatin Calcium | 165 | $2,554 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Vyndaqel, Eliquis | $589 | $1,237,386245 claims |
| NovartisEntresto | $208 | $431,042342 claims |
| Boehringer IngelheimJardiance | $288 | $259,659278 claims |
| AstraZenecaFarxiga | $14 | $156,299153 claims |
| Johnson & JohnsonXarelto | $12 | $62,99550 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 527 adult health providers in Michigan.
Other adult health in Grand Rapids
- Linda Morris McCoyGrand Rapids$59K
- Tara WebbGrand Rapids$11K
- Amy ZomerleiGrand Rapids$6K
- Jacqueline BrewerSterling Heights$138K
- Sarita RaoCanton$51K
- Susanne QuallichAnn Arbor$42K
- Nancy BermanSouthfield$39K
- Michelle MillerQuincy$24K
- Deniene KingAnn Arbor$14K
- Adama JohnsonEastpointe$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.